Levels of platelet-leukocyte aggregates in women with both thrombophilia and recurrent pregnancy loss

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 2, 2011, Pages 181-187

  Lukanov, Tzvetan Hristoforov ^a,b   Veleva, Galina Lubomirova ^a   Konova, Emiliana Ilieva ^b   Ivanov, Petar Dimitrov ^b   Kovacheva, Katia Stefanova ^b   Stoykov, Dimitur Jivkov ^c  

^a University Hospital of Pleven   (Bulgaria)

^b MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

^c University Hospital   (Bulgaria)

Author keywords

flow cytometry; platelet leukocyte aggregates; recurrent pregnancy loss; thrombophilia

Indexed keywords

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LEUKOCYTE AGGREGATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RECURRENT ABORTION; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; THROMBOPHILIA;

EID: 79952804696     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609350891     Document Type: Article

References (44)

1. Hatasaka HH Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol. 1994 ; 37 (3). 625-634. (Pubitemid 24323541)
2. Kovalevsky G., Gracia CR, Berlin JA, Sammel MD, Barnhart KT Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Intern Med. 2004 ; 164 (5). 558-563. (Pubitemid 38314453)
3. Khan S., Dickerman JD Hereditary thrombophilia. Thrombosis J. 2006 ; 4 (15). 15-32. http://www.thrombosisjournal.com/content/4/1/15 ; doi:10.1186/1477-9560-4-15.
4. Khong TY, Pearce JM, Robertson WB Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol. 1987 ; 157 (2). 360-363.
5. Redman CW, Sacks GP, Sargent IL Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999 ; 180 (2 pt 1). 499-506. (Pubitemid 29093892)
6. Salafia CM, Pezzullo JC, López-Zeno JA, Simmens S., Minior VK, Vintzileos AM Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 1995 ; 173 (4). 1097-1105.
7. Blumenfeld Z., Benjamin B. Thrombophilia-associated pregnancy wastage. Fertil Steril. 1999 ; 72 (5). 765-74. (Pubitemid 29505435)
8. Koeleman BP, Reitsma PH, Allaart CF, Bertina RM Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 1994 ; 84 (4). 1031-1035. (Pubitemid 24245865)
9. Gandrille S., Greengard JS, Alhenc-Gelas M., et al. Incidence of activated protein C resistance caused by the Arg506 Gln mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood. 1995 ; 86 (1). 219-224.
10. Brenner B., Zivelin A., Lanir N., Greengard JS, Griffin JH, Seligsohn U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood. 1996 ; 88 (3). 877-880. (Pubitemid 26333309)
11. Zoller B., Berntsdotter A., Garcia de Frutos P., Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995 ; 85 (12). 3518-3519.
12. Mandel H., Brenner B., Berant M., et al. Coexistence of hyperhomocysteinemia and factor V Leiden mutation: impact on expression of thrombosis. N Eng J Med. 1996 ; 334 (12). 763-768. (Pubitemid 26089358)
13. Brenner B., Vulfsons SL, Lanir N., Nahir M. Coexistence of familial antiphospholipid syndrome and factor V Leiden-impact on thrombotic diathesis. Br J Haematol. 1996 ; 94 (1). 166-167. (Pubitemid 26232560)
14. Li N., Hu H., Lindqvist M., Wikstrom-Jonsson E., Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol. 2000 ; 20 (12). 2702-2708.
15. Larsen E., Celi A., Gilbert GE, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989 ; 59 (2). 305-312. (Pubitemid 19264376)
16. Hamburger SA, McEver RP GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990 ; 75 (3). 550-554. (Pubitemid 20069190)
17. Sako D., Chang XJ, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993 ; 75 (6). 1179-1186. (Pubitemid 24006114)
18. Cerletti C., Evangelista V., de Gaetano G. P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost. 1999 ; 82 (2). 787-793.
19. Kaplar M., Kappelmayer J., Veszpremi A., Szabo K., Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 2001 ; 12 (7). 419-422. (Pubitemid 33097236)
20. Freedman JE, Joseph L. Platelet-monocyte aggregates bridging thrombosis and inflammation. Circulation. 2002 ; 105 (18). 2130-2132. (Pubitemid 34517152)
21. Zeller JA, Lenz A., Eschenfelder CC, Zunker P., Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without precedeing infection. Arterioscler Thromb Vasc Biol. 2005 ; 25 (7). 1519-1523. (Pubitemid 40923378)
22. Evangelista V., Manarini S., Dell'Elba G., et al. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost. 2005 ; 94 (3). 568-577. (Pubitemid 41300854)
23. Furman MI, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol. 2001 ; 38 (4). 1002-1006. (Pubitemid 32912702)
24. Htun P., Fateh-Moghadam S., Tomandl B., et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ishemia. Stroke. 2006 ; 37 (9). 2283-2287. (Pubitemid 44337170)
25. Yngen M. Platelet Function in Diabetes Mellitus. Relationship to Hyperglycaemia, Antidiabetic Treatment, and Microangiopathy. Stockholm ; Sweden: Karolinska University Press ; 2005.
26. Arellano-Rodrigo E., Alvarez-Larran A., Reverter J., et al. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with JAK2 mutational status. Haematologica. 2006 ; 91 (2). 169-175.
27. Falanga A., Marchetti M., Evangelista V., et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 2000 ; 96 (13). 4261-4266.
28. Ashman N., Macey M., Fan S. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol Dial Transplant. 2003 ; 18 (10). 2088-2096. (Pubitemid 37220316)
29. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001 ; 104 (13). 1533-1537.
30. Isermann B., Kashif M., Nawroth P. Platelet activation impairs placental function. Thromb Res. 2009 ; 123 (suppl 2). S85 - S87.
31. Harding SA, Din JN, Sarma J., et al. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost. 2007 ; 98 (2). 451-456. (Pubitemid 47260292)
32. Ivanov P., Komsa-Penkova R., Kovacheva K., et al. Impact of genetic factors on pulmonary embolism - early onset and recurrent incidences. Lung. 2008 ; 186 (1). 27-36.
33. Preston FE, Rosendaal FR, Walker D., et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996 ; 348 (9032). 913-916. (Pubitemid 26333847)
34. Rai R., Shlebak A., Cohen H., et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod. 2001 ; 16 (5). 961-965. (Pubitemid 32451834)
35. Bick RL Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group. Clin Appl Thromb Hemost. 2000 ; 6 (3). 115-125. (Pubitemid 30663117)
36. Kaptan K., Beyan C., Ifran A., Pekel A. Platelet-derived microparticle levels in women with recurrent spontaneous abortion. Int J Gynaecol Obstet. 2008 ; 102 (3). 271-274.
37. Smith GC, Pell JP, Walsh D. Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study. BMJ. 2003 ; 326 (7386). 423-424. (Pubitemid 36246313)
38. Shishehbor MH, Bhat DL Inflammation and atherosclerosis. Curr Atheroscler Rep. 2004 ; 6 (2). 131-139. (Pubitemid 38914958)
39. Pitchford SC Novel uses for anti-platelet agents as antiinflammatory drugs. Br J Pharmacol. 2007 ; 152 (7). 987-1002. (Pubitemid 350166038)
40. Martinelli I., Taioli E., Cetin I., et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000 ; 343 (14). 1015-1018.
41. Ridker PM, Henekens CH, Selhub J., Miletich JP, Malinow MR, Stampfer MJ Interrelation of hyperhomocysteinemiq, factor V Leiden and risk of future venous thromboembolism. Circulation. 1997 ; 95 (7). 1777-1782. (Pubitemid 27164393)
42. Brenner B., Sarig G., Weiner Z., Younis J., Blumenfeld Z., Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost. 1999 ; 82 (1). 6-9. (Pubitemid 29368764)
43. Hohlagschwandtner M., Unfried G., Heinze G., Huber JC, Nagele F., Tempfer C. Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. Fertil Steril. 2003 ; 79 (5). 1141-1148. (Pubitemid 36547852)
44. Sotiriadis A., Vartholomatos G., Pavlou M., et al. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol. 2007 ; 57 (2). 133-141. (Pubitemid 46099808)